Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-005220-15Phase 3Completed
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Linagliptin with Placebo (2 arms). Primary endpoint: Pulse Wave Velocity after 26 weeks. Started May 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-005220-15.